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ABSTRACT
Background. Cognitive dysfunction in fibromyalgia (FM) encompasses objective
cognitive difficulties, as measured in neuropsychological tests, and self-reported
cognitive complaints. Although it has been suggested that FMpatients display problems
in working memory, the data are inconsistent, and the overall working memory status
of the patients is unclear. It is also not clear whether the working memory problems are
related to cognitive complaints or how the dyscognition is affected by the characteristic
clinical symptoms of FM.
Methods. To clarify these aspects, we explored the neuropsychological performance
for different components of working memory and the subjective self-perception of
cognitive status in a sample of 38 womenwith FM. They were compared with amatched
group of 32 healthy women.
Results. Our findings suggested that the FMpatients do not differ fromhealthy controls
in their overall working memory functioning. Only a poor performance was found in
a single task of visuospatial working memory, mediated by the presence of depressive
symptoms, fatigue and pain. The FM patients also displayed a higher level of perception
of cognitive difficulties than healthy controls, and this difference was mediated by
depression and fatigue. Furthermore, cognitive complaints in FM patients were only
associated with a lower verbal WM capacity.
Discussion. FM patients have a subtle specific impairment in their working memory
functioning, as well as elevated concern about their cognitive status. These findings
suggest a disconnection between neuropsychological performance and subjective
complaints. In FM patients, clinical variables such as pain, fatigue, and depression
play an important role in dyscognition, as assessed by both objective and subjective
measures, and should be taken into account in future research.
Subjects Neuroscience, Cognitive Disorders, Psychiatry and Psychology, Rheumatology,
Women’s Health
Keywords Chronic pain, Dyscognition, Working memory, Cognitive complaints, Fibromyalgia,
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INTRODUCTION
Fibromyalgia (FM) is a chronic disease of uncertain aetiology that affects 2.7% of the
population, with a female-to-male ratio of 3:1 (Queiroz, 2013). It is characterized by
widespread musculoskeletal pain and other symptoms such as fatigue, stiffness, mood
disturbance, restless sleep and cognitive dysfunction (Crombez et al., 2013). Cognitive
dysfunction in FM, also called dyscognition, encompasses objective cognitive difficulties
observed in neuropsychological tests and also self-reported cognitive complaints (Glass,
2009).
Regarding objective cognitive difficulties, it has been proposed that patients with FM
have particular problems in working memory (WM) because they perform poorly in tasks
involving distraction (Katz et al., 2004) or complex and rapidly changing environments
(Glass, 2009; Ceko, Bushnell & Gracely, 2012). However, according to multicomponent
models, WM represents a multifaceted construct that requires full exploration. One
of the most influential models (Baddeley & Hitch, 1974; Baddeley et al., 1986; Baddeley,
1996; Miyake & Shah, 1999) proposes that WM is composed of a central executive and
two subsystems for temporary storage and rehearsal of auditory-verbal and visuo-spatial
information, the phonological loop and the visuo-spatial sketchpad, respectively. The
central executive system converges aspects of attention, memory and executive functions,
and is also assumed to be fractionable in different components, including the capacity
to maintain, monitor, manipulate and update information, inhibition, and attentional
flexibility.
Several studies have revealed that FM patients show deficits in the phonological loop
component of WM (Roldán-Tapia et al., 2007; Leavitt & Katz, 2008; Munguía-Izquierdo
et al., 2008; Di Tella et al., 2015), in the visuospatial sketchpad (Luerding et al., 2008), and
in different aspects of the central executive system related to WM, such as the capacity
to update and inhibit information (Seo et al., 2012; Akdoğan et al., 2013; Cuevas-Toro
et al., 2014; Martinsen et al., 2014; Cherry et al., 2014; Coppieters et al., 2015; Tesio et al.,
2015; Di Tella et al., 2015). Other authors have either not found any evidence of altered
performance for these WM components in FM patients (Landrø, Stiles & Sletvold, 1997;
Suhr, 2003; Walteros et al., 2011; Glass et al., 2011; Ceko, Bushnell & Gracely, 2012; Mohs
et al., 2012; Kim et al., 2012; Veldhuijzen, Sondaal & Oosterman, 2012; Schmidt-Wilcke et
al., 2014; Tesio et al., 2015), or have explained it by depression or other symptoms of FM
such as fatigue and pain (Landrø, Stiles & Sletvold, 1997; Dick, Eccleston & Crombez, 2002;
Suhr, 2003; Munguía-Izquierdo et al., 2008; Kim et al., 2012; Gelonch et al., 2016). Thus,
it is difficult to reach conclusions about the presence of WM deficits in FM patients.
Furthermore, the variety of tasks used to assess WM and the diversity of samples in
previous research (Berryman et al., 2013) hinder demonstration of the overall functioning
of FM patients in WM. To the best of our knowledge, no research to date has evaluated
the different components of WM together in the same group of FM patients, as evidenced
in recent reviews and meta-analyses (Gelonch et al., 2013; Berryman et al., 2013; Wu et al.,
2018).
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Regarding subjective cognitive complaints, the term fibrofog is used to refer to the loss
of mental clarity and to the impaired attention and memory, which are frequently reported
by FM patients. It is one of the most prevalent symptoms of FM and is often considered
more disabling than the pain itself. Despite being a very common and disruptive symptom,
cognitive complaints are not well studied and seem to have been overlooked in research
on FM dyscognition (Glass, 2009). However, clinicians and researchers highlight the need
for further research into the cognitive dysfunction experienced by FM patients, and this
symptom has in fact been incorporated into the latest diagnostic criteria of FM (Wolfe et
al., 2010).
Previous research has suggested that characteristic symptoms of the disease, such as
depression, fatigue and pain have an impact on subjective cognitive complaints in FM
patients (Suhr, 2003; Castel et al., 2008; Williams, Clauw & Glass, 2011; Kravitz & Katz,
2015; Gelonch et al., 2016; Gelonch et al., 2017). This influence could be explained by the
fact that the affective and physical variables of the disease may exacerbate the amount of
perceived effort required to perform a cognitive task (Bar-On Kalfon et al., 2016). Thus,
the subjective cognitive perception of the patients would be altered, increasing their
complaints, but not necessarily their objective performance. This would contribute to a
disconnection between self-reported cognitive complaints in FM patients and measurable
objective deficits.
Few studies to date have investigated the extent towhich cognitive complaints can reliably
indicate impaired cognitive function in FM; the findings of these and of studies with other
clinical populations (Alegret et al., 2015), older adults (Crumley, Stetler & Horhota, 2014;
Chin et al., 2014; Burmester, Leathem &Merrick, 2016) and working middle-aged adults
(Stenfors et al., 2013) have been controversial. Some studies have observed a relationship
between FM patients’ complaints and the performance of neuropsychological tests (Park
et al., 2001; Tesio et al., 2015), supporting the use of complaints as a valid indicator of
cognitive problems. By contrast, other authors have highlighted the disconnection between
the subjective experience of cognitive problems and the objective reality of cognitive
performance in FM patients (Walitt et al., 2016; Gelonch et al., 2016).
In summary, the overall working memory status of FM patients is not clear, as the
different components of working memory have not yet been evaluated in the same group
of patients. In addition, the role of clinical symptoms of FM on dyscognition has not yet
been determined. It is also not clear whether cognitive complaints in FMpatients are related
to working memory performance in neuropsychological tests. Therefore, the aims of this
study were (1) to determine whether there are significant differences between FM patients
and healthy control subjects in a series of objective WMmeasures and subjective cognitive
measures, analyzing the effect of pain, depression and fatigue on the possible differences;
(2) to explore the relationship between the objectiveWM and subjective cognitivemeasures
in FM patients.
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MATERIALS AND METHODS
Participants
Thirty-eight women diagnosed with fibromyalgia and 33 healthy controls (HC), women
matched for age, education, laterality and menopausal status, were enrolled. The
participants gave their written informed consent for their involvement in the study,
approved by the Galician Autonomous Committee for Research Ethics (2013/582), and
conducted in accordance with the Declaration of Helsinki. Patients were referred from
different medical centres and FM associations in Galicia (NW Spain). Healthy controls
were recruited from the community. The participants were aged between 28 and 64 years
old and received 25 ¤ to cover travelling expenses. The inclusion criterion for the FM
group was a diagnosis of the disease by a rheumatologist, meeting the diagnostic criteria
established in 1990 (Wolfe et al., 1990). A history of any medical condition associated
with cognitive dysfunction, mental illness or psychiatric disorders (except for anxiety and
depression symptomatology) was an exclusion criterion for all participants. In addition,
healthy controls (HC) should not have any chronic pain condition. For ethical reasons,
patients were not asked to withdraw prescribed medical treatments. Demographic and
clinical characteristics of the groups are shown in Table 1.
Measures
Sociodemogaphic and clinical information
Clinical and sociodemographic data on the participants were obtained via a semi-structured
interview. The intensity of pain and of fatigue experienced in the previous week were
measured on 0–10 Visual Analogue Scales (VAS). Depressive symptoms were assessed using
the Spanish version of the Beck Depression Inventory (Beck, Steer & Brown, 1996). The
handedness of participants was assessed by administration of the Edinburgh Handedness
Inventory (Oldfield, 1971).
Working memory assessment
A multicomponent approach was used to assess WM (Baddeley et al., 1986; Miyake &
Shah, 1999; Tirapu-Ustárroz et al., 2005; Verdejo-García & Bechara, 2010). The visuospatial
sketchpad, the phonological loop and different aspects of the central executive system
related to WM (such as the capacity to maintain, monitor, manipulate and update
information, as well as inhibition and attentional flexibility) were assessed by the tasks
described below.
The Digit self-Ordering Task (DOT; Sunderland, Harris & Gleave, 1984; Petrides et al.,
1993) allowed us to obtain information about the monitoring process that the subject
required for successful completion of tasks. Participants were asked to say out loud
numbers between 1 and 10 at random, without repeating or forgetting any digits in ten
trials. The sum of omission errors and repetitions over the ten trials was recorded as the
final score.
The 5-Digit Test (Sedó, 2004) was used to assess aspects of WM related to the executive
system. The test is described as a numerical Stroop task, with the advantage of displaying
minimal verbal content and thus permitting its application in multilingual contexts, as in
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 4/22
Table 1 Characteristics of FM patients and controls.
FM patients healthy controls t , χ2 orU p
N = 38 N = 33
AgeM (SD) 47.71 (9.63) 47 (9.01) U = 609 .835
Education (%) X 2= 0.098 .952
Primary school 36.8 33.3
High school 36.8 39.4
Higher studies 26.3 27.3
Menopausal women (%) 47.4 45.5 X 2= 0.026 .872
Right handed (%) 97.4 97 X 2= 2.02 .364
BDIM (SD) 24.11 (13.46) 10.08 (5.54) t =−5.56 <.001
VAS (cm)
PainM (SD) 6.68 (1.71) 2.98 (3.25) t =−6.048 <.001
FatigueM (SD) 7.70 (1.99) 3.22 (2.55) t =−7.36 <.001
5DT Reading (s)M (SD) 22.65 (4.63) 20.79 (3.88)
n-back RT (s)
1-backM (SD) 0.60 (0.12) 0.55 (0.12)
2-backM (SD) 0.64 (0.12) 0.59 (0.13)
Medication






M (SD), mean (standard deviation); BDI, Beck Depression Inventory; VAS, Visual Analogue Scale; 5DT, 5-Digit Test; RT,
Reaction Time.
the case of the region where the present study was carried out. Further, it assesses both the
ability to cope with interference and to alternate between mental processes—flexibility-,
and also the speed of cognitive processing. It is composed of four subtests: in part 1
(Reading ) participants were asked to read the digit presented in a series of text boxes, each
containing as many repetitions of the digit as it indicates itself. In part 2 (Counting ), the
boxes contained asterisks and the participants were asked to state the number of these
in each box. In part 3 (Focusing ), the boxes were similar to those in part 1, except the
identity of the digit in each box did not correspond to the number of digits in the box.
Participants were then asked to state the number of digits and to ignore their identity. In
part 4 (Switching ), an extra clue indicates whether the participant must report the number
of digits or their identity (reading or counting). In all parts of the test, performance was
measured in terms of the time required to complete the task. Inhibition (Focusing minus
Reading ) and Flexibility (Switching minus Reading ) scores were calculated to measureWM
components related to the executive system.
The Letter-Number Sequencing Subtest of the Spanish version of theWechsler Memory
Scale III (Wechsler, 1997) was used to provide data on the maintenance and manipulation
of verbal information capacity in WM. A series of mixed and randomly ordered lists of
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Figure 1 Example of a 2-back task.
Full-size DOI: 10.7717/peerj.5907/fig-1
letters and numbers of increasing length were presented orally. The participants were asked
to repeat the lists in a certain order: first stating the numbers in ascending order followed
by the letters in alphabetical order. The span score was recorded.
The Spatial Localization Subtest of the Spanish version of the Wechsler Memory Scale III
(Wechsler, 1997) was used to assess aspects of the visuospatial sketchpad and the capacity to
manipulate visuospatial information while in temporary storage. This task consists of nine
cubes placed on a board that the examiner taps in a specific order. The participants were
asked to observe the sequence of blocks tapped and repeat it in the Forward part of the
task. In the Backwards task, the subjects were asked to repeat the sequence in reverse order.
The task started with a series of two blocks and gradually increased in length. Forward and
Backwards span scores were recorded.
The Digit Subtest of the Spanish version of the Wechsler Memory Scale III (Wechsler,
1997) was administered to evaluate the phonological loop and the ability of subjects to
manipulate verbal information while in temporary storage. Participants were asked to
repeat chains of digits of increasing length in the given order in the Forward task and in
reverse order in the Backwards task. Forward and Backwards span scores were recorded.
Visual 1-back and 2-back tasks were also administered, in order to assess the ability to
maintain, monitor, manipulate and update information inWM. PsychoPy software (Peirce,
2008) was used to design and present the tasks on a computer. Subjects were required to
monitor a sequence of digits (0 to 9) presented one by one, and to press a button in a
response box with the index finger of their dominant handwhen a target stimulus appeared.
The target stimuli were the same numbers presented one trial (1-back condition) or two
trials (2-back condition) before (Fig. 1). Each task consisted of 220 trials, with a 30% of
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target stimuli. The percentage of correct answers and the number of false positives in each
task were recorded for posterior analysis.
In addition to the WM measures described above, the processing speed was also
measured using the 5-Digit Test Reading subtest score and reaction times in the 1-back
and 2-back tasks. Although processing speed is not a subcomponent of working memory,
it is present in many WM tasks. To ensure that our results reflected the performance of
the participants strictly in WM components, we controlled for possible between-groups
differences in processing speed.
Subjective cognitive complaints
With a view to obtaining information about the overall cognitive complaints, the
participants were questioned about ‘‘Trouble thinking or remembering’’ in item I.2 of
the Fibromyalgia Survey Questionnaire (Carrillo-de-la Peña et al., 2015). The answer was
coded as 0 (not present), 1 (slight problems), 2 (moderate problems) and 3 (severe
problems).
As subjective reports of cognitive impairment are considered to be accurate if the
subjective questionnaire evaluates specific types of behaviour (Hertzog et al., 2000), the
Spanish Version of the Memory Failures of Everyday Questionnaire was also administered
(Sunderland, Harris & Gleave, 1984; Lozoya-Delgado, Ruiz-Sánchez de León & Pedrero-
Pérez, 2012). The MFE-30 is a Likert 5-point (between ‘never’ and ‘very often’)
questionnaire, comprising 30 items related to complaints in different cognitive domains.
The MFE-30 Total score (range 0–120) was calculated as the sum of all items. This
score was ranked into four categories: 0–7, 8–35, 36–50 and over 50, indicating optimal
performance, normal, mild deterioration and moderate deterioration respectively. In order
to obtain additional information from the MFE-30 questionnaire, two additional scores
were considered: one was calculated as the sum of items related to general functioning
(General Function score), and the other was determined as the sum of items linked to more
specific activities in daily living (Daily Life score) (Lozoya-Delgado, Ruiz-Sánchez de León
& Pedrero-Pérez, 2012).
Procedure
A psychologist trained in neuropsychological assessment collected all the data, following
a standardized protocol. Demographic and clinical information were obtained during the
evaluation session, after participants had provided written informed consent to take part
in the study. Information about laterality and subjective complaints was obtained before
participants performed the paper and pencil WM tests and the computerized n-back tasks.
The order of administration of the tasks was maintained for all the participants.
Data collection sessions took place in the Faculty of Psychology of the University of
Santiago de Compostela. Each session lasted approximately 50 min, depending on the
ability of each participant.
Statistical analysis
Means and standard deviations were used to describe the quantitative variables, while
absolute frequencies and percentages were used for the qualitative measures. Normality of
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variables was tested with the Shapiro–Wilk test. Differences between FM and HC groups in
clinical and sociodemographic variables were analyzed using Student’s t -test or Chi-square
test, depending on the type of variable considered. Group differences in processing speed
were analyzed by multivariate analysis of variance (MANOVA) with n-back reaction times
and 5-Digit Reading subtest score as dependent variables.
Differences between the groups in the WM scores were tested for significance by
MANOVA. Univariate analyses were also performed to study each measure independently.
The size of the effect was measured using the eta-squared coefficient (η2), in which values
of >0.01, >0.06 and >0.14 were respectively defined as small, medium and large. Analysis
of covariance (ANCOVA) was used to statistically control the effect of depression, fatigue
and pain when group differences inWMmeasures were found to be significant. Bonferroni
correction for multiple comparisons was applied.
In order to examine the individual performance of FM patients in WM tasks that could
bemasked in group analyses, and to further investigate the clinical context of these patients,
individual scores were also analyzed. The Z scores for fibromyalgia patients were computed
on the basis of our own control data, and the percentage of patients who performed poorly
in each WM test (Z scores ≤−1) was then determined.
Differences between groups in the percentages of general subjective cognitive complaints,
as measured by the FSQ I.2 score and the MFE-30 rated Total score, were analyzed by
Chi-square tests. On the other hand, differences between groups in detailed cognitive
complaints, measured by theMFE-30 Total, General Function, and Daily Life scores, were
analyzed by Student’s t -test for independent samples. The effect size was calculated using
Cohen’s d, for which values of <0.20, <0.50 and <0.80 were considered small, medium
and large. Analysis of covariance (ANCOVA) was used to statistically control the effect
of depression, fatigue and pain when group differences in cognitive complaints were
significant.
Associations between WM performance and cognitive complaints for FM patients were
quantified using Spearman’s bivariate correlations.
All statistical analyses were performed using IBM SPSS Statistics 20 (IBM SPSS, 2011).
Missing data were treated with the multiple imputation procedure implemented in SPSS.
Differences in results were considered statistically significant at p <.05.
RESULTS
Sample characteristics
There were no significant differences between the FM and HC groups in age, education,
menopausal status or laterality. There were also no significant differences in processing
speed measures, as indicated by the MANOVA with the n-back reaction times and the 5-
Digit Reading subtest scores [Wilks’ λ= 0.910 and F(1,59)= 1.887, p= .142, η2= 0.090].
However, as expected, FM patients obtained higher scores (p< .001) in measures of
depression (BDI) and pain and fatigue (VAS). Detailed statistical data are shown in
Table 1.
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Table 2 Working memory performance of the FM patients and healthy control groups.
FM Patients Healthy Controls p η2
Mean (SD) N = 38 Mean (SD) N = 33
DOT 8.18 (6.55) 8.48 (8.14) .765 .002
5DT Inhibition 17.93 (6.43) 17.58 (6.68) .558 .006
5DT Flexibility 30.65 (10.36) 30.95 (9.04) .690 .003
L&N 5.03 (0.85) 4.85 (1.17) .897 .000
Spatial L. Forward 5.55 (1.15) 5.42 (1.2) .702 .002
Spatial L. Backwards 4.76 (1.28) 5.39 (1.29) .023* .085
Digit Forward 5.47 (1.006) 5.64 (1.14) .655 .003
Digit Backwards 4.58 (1.004) 4.42 (0.969) .405 .012
False Pos 1-back 1.78 (3.85) 0.82 (1.60) .221 .025
False Pos 2-back 6.53 (9.04) 7.79 (10.36) .613 .004
% Correct 1-back 92.97 (8.65) 96.09 (4.30) .084 .050
% Correct 2-back 75.52 (10.62) 77.01 (12.03) .609 .004
Notes.
DOT, Digit self-Ordering Task; 5DT, 5-Digit Test; L&N, Letter-Number Sequencing Subtest; Spatial L., Spatial Localiza-
tion Subtest; false Pos, false positives.
*p< .05.
Objective working memory performance
The overall MANOVA for the WM measures revealed no significant differences between
the FM patients and the HC group [Wilks’ λ= 0.751 and F(1,59)= 1.328, p= .234,
η2= .249]. Univariate tests showed that FM patients only scored significantly lower on
the Backwards Spatial Localization Subtest, with a medium size effect (F(1,59)= 5.474,
p= .023, η2= .085) (Table 2). This significant difference disappeared when the BDI
[F(1,58)= 0, p= .986, η2= .0], VAS fatigue [F(1,58)= .387, p= .536, η2= .007] or VAS
pain [F(1.66)= .242, p= .625, η2= .004] scores were included as covariates.
Regarding the analysis of individual WM performance in FM patients relative to healthy
controls, Fig. 2 shows the percentage of FM patients with deficient performance (Z ≤−1)
for each measure. The percentage of patients with deficient performance was highest (47%)
for the span score obtained in the Backwards Spatial Localization Subtest. In addition, 21%
of the patients exhibited poor performance in the Forward Spatial Localization Subtest, and
in the correct responses of the 1-back task.
Subjective cognitive complaints
Compared to healthy controls, FM patients showed a higher percentage of cognitive
complaints measured by the FSQ I.2 item (p< .001): 78.9% of patients compared to
12.5% of HC reported moderate or severe cognitive problems. Furthermore, analysis of
the MFE-30 ranked Total score also revealed differences between groups (p< .001), with
71.1% of patients reporting mild or moderate impairment relative to 45.4% of healthy
controls. All these data are shown in Table 3.
Significant differences between groups were also found for cognitive complaints in
the MFE-30 Total score (p< .001), and in the General Function (p< .001) and Daily
Life (p< .001) scores, with FM patients obtaining higher scores (Table 3). Results
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Figure 2 Percentage of FM patients with deficient performance inWMmeasures.DOT, Digit self-
Ordering Task; 5DT, 5-Digit Test ; L&N, Letter–Number Sequencing Subtest ; SL, Spatial Localization Sub-
test ; False Pos, False positives
Full-size DOI: 10.7717/peerj.5907/fig-2
Table 3 Subjective cognitive complaints in FM patients and healthy controls.
FM Patients Healthy Controls t or X 2 d p
N = 38 N = 33
FSQ I.2 (%)a X 2= 33.01 <.001
0: No problem 2.6 34.4
1: Slight problems 18.4 53.1
2: Moderate problems 50 12.5
3: Severe problems 28.9 0
MFE-30 Scores
Rated total (%) X = 22.66 <.001
Optimal performance 2.6 3
Normal performance 26.3 51.5
Mild impairment 15.8 42.4
Moderate impairment 55.3 3
TotalMean (SD) 53.091 (25.62) 30.285 (12.90) t =−4.827 1.124 <.001
GeneralMean (SD) 34.118 (19.40) 17.293 (9.28) t =−4.755 1.106 <.001
Daily lifeMean (SD) 18.973 (7.04) 12.992 (4.69) t =−4.256 0.999 <.001
Notes.
FSQ I.2, Fibromyalgia Survey Questionnaire ‘‘Trouble thinking or remembering’’ item; MFE-30, Memory Failures in
Everyday Questionnaire; General, general function.
aOne participant did not complete the FSQ.
of ANCOVAs showed that the significant difference between groups in the MFE-30
Total score disappeared when BDI [F(1,53)= 2.819, p= .099] or fatigue VAS scores
[F(1,52)= 1.931, p= .171] were included as covariates, but not when pain VAS score was
included [F(1,54)= 8.187, p= .006]. Moreover, the additional measures of the MFE-30,
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Table 4 Correlations betweenWMperformance and cognitive complaints in FM patients.
MFE-30 MFE-30 MFE-30
Total General function Daily life
DOT −.211 −.164 −.316
5DT Inhibition .147 .161 .090
5DT Flexibility .202 .230 .100
L&N −.228 −.251 −.138
Spatial L Forward −.051 −.055 −.033
Spatial L Backwards −.094 −.150 0.72
Digit Forward −.435** −.445** −.356*
Digit Backwards .020 −.010 −.099
False Pos 1-back −.191 .181 −.188
False Pos 2-back .200 .191 .195
% Correct 1-back −.097 −.122 −.019
% Correct 2-back −.233 −.251 −.155
Notes.
FSQ I.2, Fibromyalgia Survey Questionnaire ‘‘Trouble thinking or remembering’’; MFE-30, Memory Failures in Everyday
Questionnaire; DOT, Digit self-Ordering Task; 5DT, 5-Digit Test; L&N, Letter-Number Sequencing Subtest; Spatial L.,
Spatial Localization Subtest; False Pos, false positives.
*p< .05.
**p< .01.
General Function and Daily Life scores, followed the same pattern, with no significant
differences when BDI [for theMFE-30 General Function score: F(1,53)= 2.017, p= .161;
for Daily Life score: F(1,53)= 3.727, p= .059] or fatigue scores [for General Function
score: F(1,52)= 1.541, p= .220; for Daily Life score: F(1,52)= 2.287, p= .137] were
added as covariates; however, the significant differences remained when the pain score
was included [for General Function score: F(1,54)= 8.701, p= .005; for Daily Life score:
F(1,54)= 4.567, p= .037].
Relationship between objective working memory performance and
subjective cognitive complaints
Correlations between the measures of objective WM performance and the subjective
cognitive complaints evaluated by the MFE-30 questionnaire were calculated for the FM
patients (Table 4). The only significant (negative) correlations were found between the
Digit Forward span score and the General Function, Daily Life and Total scores from the
MFE-30.
DISCUSSION
This study examined the objective performance of working memory (WM) tasks and
the subjective cognitive complaints in a group of female FM patients. The patients were
compared to a healthy control group of women matched for age, educational level and
laterality, as well as menopausal status and speed of information processing. Possible effects
of pain, depression and fatigue on group differences were also taken into account.
Overall, the results indicate that FM patients do not differ from healthy controls
in WM functioning. Only the performance of a task related to visuospatial WM was
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significantly poorer in the FM patients than in controls, and the differences were mediated
by the presence of depressive symptoms, fatigue and pain. Analysis of the individual
performances revealed deficient execution of this visuospatial task in almost half of the
FM patients. Regarding subjective cognitive complaints, and as expected, patients showed
a greater perception of cognitive difficulties than healthy controls, even in activities of
daily living. This difference was independent of pain but was explained by depression and
fatigue. Furthermore, cognitive complaints in FM patients were only associated with a
lower verbal WM capacity.
The results of our study show that FM patients did not perform less well than healthy
controls in terms of the global outcome across all the WM tasks. This finding is consistent
with those of earlier studies using tasks related either to the phonological loop (Landrø,
Stiles & Sletvold, 1997; Suhr, 2003; Luerding et al., 2008; Walteros et al., 2011; Kim et al.,
2012; Cherry et al., 2014; Coppieters et al., 2015), the visuospatial sketchpad (Kim et al.,
2012), monitoring and updating information capacities (Suhr, 2003; Ceko, Bushnell &
Gracely, 2012; Tesio et al., 2015), the ability to manipulate verbal information online
(Landrø, Stiles & Sletvold, 1997; Roldán-Tapia et al., 2007; Luerding et al., 2008; Kim et
al., 2012; Cherry et al., 2014), or inhibition and attentional flexibility capacities (Suhr,
2003; Walteros et al., 2011; Glass et al., 2011; Mohs et al., 2012; Veldhuijzen, Sondaal &
Oosterman, 2012; Martinsen et al., 2014; Schmidt-Wilcke et al., 2014; Cherry et al., 2014).
However, our findings contrast with those of previous studies showing impairment on
WM performance in FM patients (Dick, Eccleston & Crombez, 2002; Roldán-Tapia et al.,
2007; Leavitt & Katz, 2008; Munguía-Izquierdo et al., 2008; Luerding et al., 2008; Seo et al.,
2012; Akdoğan et al., 2013; Martinsen et al., 2014; Coppieters et al., 2015; Di Tella et al.,
2015). There are several possible explanations for this discrepancy. First, some authors
of previous studies have interpreted group differences in processing speed scores as WM
deficits (Veldhuijzen, Sondaal & Oosterman, 2012; Akdoğan et al., 2013; Martinsen et al.,
2014; Cherry et al., 2014; Coppieters et al., 2015; Tesio et al., 2015), while we considered the
accuracy scores. Second, other authors did not specify theWMdomains assessed when tasks
involved different scores (Suhr, 2003; Luerding et al., 2008; Walteros et al., 2011), whereas
we associated each score with a WM domain. Finally, some authors compared cognitive
performance of FM patients with normative data (Landrø, Stiles & Sletvold, 1997; Luerding
et al., 2008), whereas we used a matched control group.
The overall performance of patients was comparable to that of controls in the tasks
evaluating the above-mentioned domains; however, the patients obtained a lower span
score in the Backwards Spatial Localization Subtest (Wechsler, 1997), which is related to the
ability to maintain and manipulate visuospatial information. Although scarce attention has
been paid to the visuospatial WM domain in previous research, Kim et al. (2012) obtained
similar results using a computerized version of the task. Luerding et al. (2008) also reported
similar findings, although they did not specify whether they used the forward or backwards
part of the task; these authors also used normative data.
We observed that the significant difference between the groups in visuospatial WM span
can be explained by the intensity of fatigue, depression, and pain reported by FM patients,
as previously suggested (Kim et al., 2012). As these symptoms are diagnostic criteria for FM,
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intrinsic characteristics of the disease seem to mediate poor performance in visuospatial
WM.
Analysis of the individual performance of FM patients showed that almost half of the
patients showed deficient performance in the Backwards Spatial Localization Subtest ; thus,
in their capacity to manipulate visuopatial information while in temporary storage. These
findings also showed that a fifth of the patients displayed deficient performance in the
forward part of the test, related to the visuospatial sketchpad, and also in the correct
response score of the 1-back task. Given that a deficient performance was not observed in
the false positive score in this task, it is possible that updating, but not inhibition, capacities
are affected in FM patients. However, the exploratory nature of this analysis, the lack of
such deficiency in the 2-back task (maybe due to practice effects caused by the order of
task administration), and the scarcity of previous data, make interpretation of the findings
difficult. Only two previous studies analysed individual performance to study cognition in
FM (Tesio et al., 2015; Di Tella et al., 2015) and the data are not comparable to the present
data. The previous studies did not include visuospatial working memory measures and
used normative data to establish individual performance.
Regarding subjective cognitive complaints, the findings also reveal a widespread presence
of subjective cognitive complaints in FM patients. They differed from controls in the
perception of their overall memory state, measured by the FSQ I.2. From a more detailed
perspective, FM patients also reported more cognitive complaints, through items of the
MFE-30, both in the Total score and in specific scores related to general functioning
and daily living. These findings represent evidence of the ubiquity of the concern about
cognitive functioning expressed by FM patients, as reflected in previous studies (Grace et
al., 1999; Glass & Park, 2001; Park et al., 2001; Glass et al., 2005; Castel et al., 2008; Arnold
et al., 2008; Williams, Clauw & Glass, 2011; Tesio et al., 2015; Kravitz & Katz, 2015; Walitt
et al., 2016; Gelonch et al., 2016; Schmaling & Betterton, 2016).
Our results also showed that the differences in cognitive complaints between FMpatients
and controls are explained by fatigue and depressive symptoms, but not by pain. The
influence of mood symptoms and fatigue in subjective perception of cognitive functioning
has also been reported in other studies with FM patients and other clinical populations
(Castel et al., 2008; Williams, Clauw & Glass, 2011; Svendsen et al., 2012; Balash et al., 2013;
Chin et al., 2014; Walitt et al., 2016; Gelonch et al., 2016; Gelonch et al., 2017). Studies have
shown that memory complaints in patients with chronic pain are not related to pain
intensity, but have been related to mood conflicts, and specially depression (Jamison,
Sbrocco & Parris, 1989; McCracken & Iverson, 2001). Therefore, our results seem to agree
that the perceived cognitive impairment does not appear to be a consequence of pain but
is part of a cluster of symptoms related to fatigue and mood disorders present in many
chronic diseases, including fibromyalgia. This symptomatology may exacerbate the feeling
in these patients that they are not capable, or that they require a greater effort in the
short term to perform a certain cognitive task (Bar-On Kalfon et al., 2016). This should
be considered when developing intervention strategies in FM patients, since treatments
aimed at reducing physical and affective symptoms could also lead to improvements in
their subjective cognitive perception.
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According to data from previous studies (Walitt et al., 2016; Gelonch et al., 2016), our
results show a discrepancy between the scarce objectiveWMdeficits and the broad presence
of subjective cognitive impairment in FM patients. This discrepancy is consistent with the
idea that subjective and objective measures encompass different neural processes (Gelonch
et al., 2017), as suggested in studies showing altered brain activity in FM patients when
performing WM tasks, even in the absence of behavioural impairment (Luerding et al.,
2008; Glass et al., 2011; Ceko, Bushnell & Gracely, 2012; Seo et al., 2012; Schmidt-Wilcke et
al., 2014;Walitt et al., 2016; González-Villar et al., 2017).
Results of the correlational analyses betweenmeasures ofWMobjective performance and
cognitive complaints also support the discrepancy between the objective and subjective
outcomes in FM patients. They only showed negative relationships between the Digit
Forward Subtest span and theMFE-30 scores. Thus, a lower capacity of verbal WMmay be
related to more cognitive complaints in FM patients, as also observed in a previous study
(Park et al., 2001).
One possible explanation for themarked differences between the objective and subjective
outcomes in FM patients is that the patients may develop compensatory strategies (Jessen
et al., 2014) and thus overcome the cognitive impairment during a single task session, as
a one-off effort. However, the patients cannot sustain this level of exertion in their daily
lives, and therefore they report day-to-day difficulties (Williams, Clauw & Glass, 2011).
Overexertion may also explain other symptoms characteristic of the disease, such as the
high levels of fatigue and depression, which we found to explain the cognitive complaints
in the FM patients in the present study. Further research is needed to clarify this hypothesis
and the role of characteristic symptoms of the disease on both objective and subjective
cognitive measures in FM patients.
One limitation to consider in interpreting our results is that, as in many studies
involving patients with chronic pain, we were faced with the difficult challenge of
monitoring medication intake. These patients do not tend to be constant in their intake, are
polymedicated, and their prescribed drugs are continuously beingmodified due to the slight
or lack of efficacy of their medication. Participants were asked not to take more drugs than
necessary but, for ethical reasons, the prescribed medication was not withdrawn. While
this lack of control may have effects—positive or negative—on cognitive functioning,
temporary discontinuation of medication may also induce negative effects on cognitive
function or alterations in brain activity. Nonetheless, the study sample was representative
of FM patients, who very often take combinations of drugs. Another limitation of this
study is that we count on a modest sized sample, although groups were well matched. This
limitation is present in large part of the literature concerning cognitive dysfunction in
fibromyalgia and stresses the need to conduct studies with larger samples in the future.
Finally, from a clinical perspective, the findings of our work contribute to the
accumulated evidence that there is a need to increase the interest in FM dyscognition.
Future research approaches should consider the importance of cognitive complaints and
the, although punctual, cognitive impairment in FM patients. It would be worthwhile
to characterize these patients through studies with larger samples, including a complete
neuropsychological assessment and a functional impact evaluation of both their objective
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and subjective cognitive status. With this approach, research could ultimately study in FM
patients the presence of Minor Neurocognitive Disorder (American Psychiatric Association,
2013).
CONCLUSION
This study highlights how difficult it is to show a large objective alteration in WM
performance, apart from an occasional deficit in a specific component, how easy it is
to show a subjective difference, and how poorly these are correlated in patients with
fibromyalgia.
ACKNOWLEDGEMENTS
We would like to express our gratitude to the fibromyalgia patients of the community
of Galicia for their indispensable participation in this research, and especially to the
organizations Acofifa and Agafi for their support and collaboration.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
This work was supported by funding from the Galician Government (Consellería
de Cultura, Educación e Ordenación Universitaria; axudas para a consolidación e
Estruturación de unidades de investigación competitivas do Sistema universitario deGalicia
[grant number GPC2014/047] and funding from the Spanish Government (Ministerio de
Economía y Competitividad) [Grant Number PSI2013-45818-R]. Alberto González-Villar
was supported by a grant from the Fundación Ramón Domínguez. The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Grant Disclosures
The following grant information was disclosed by the authors:
Galician Government (Consellería de Cultura, Educación e Ordenación Universitaria;
axudas para a consolidación e Estruturación de unidades de investigación competitivas do
Sistema universitario de Galicia): GPC2014/047.
Spanish Government (Ministerio de Economía y Competitividad): PSI2013-45818-R.
Fundación Ramón Domínguez.
Competing Interests
The authors declare there are no competing interests.
Author Contributions
• Marina Pidal-Miranda performed the experiments, analyzed the data, contributed
reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed
drafts of the paper, approved the final draft.
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 15/22
• Alberto Jacobo González-Villar performed the experiments, contributed reagents/mate-
rials/analysis tools, approved the final draft.
• María Teresa Carrillo-de-la-Peña conceived and designed the experiments, approved
the final draft.
• Elena Andrade analyzed the data, approved the final draft.
• Dolores Rodríguez-Salgado conceived and designed the experiments, analyzed the data,
contributed reagents/materials/analysis tools, prepared figures and/or tables, authored
or reviewed drafts of the paper, approved the final draft.
Human Ethics
The following information was supplied relating to ethical approvals (i.e., approving body
and any reference numbers):
The participants gave their written informed consent for their involvement in the study,
approved by the Galician Autonomous Committee for Research Ethics (2013/582), and
conducted in accordance with the Declaration of Helsinki.
Data Availability
The following information was supplied regarding data availability:
The raw data are available in the Supplemental Information 1.
Supplemental Information
Supplemental information for this article can be found online at http://dx.doi.org/10.7717/
peerj.5907#supplemental-information.
REFERENCES
Akdoğan S, Ayhan FF, Yıldırım Ş, Borman P. 2013. Impact of fatigue on cognitive func-
tioning among premenopausal women with fibromyalgia syndrome and rheuma-
toid arthritis: the controlled study. Journal of Musculoskeletal Pain 21:135–146
DOI 10.3109/10582452.2013.806977.
Alegret M, Rodríguez O, Espinosa A, Ortega G, Sanabria A, Valero S, Hernández I,
Rosende-RocaM, Vargas L, Abdelnour C, Mauleón A, Gailhajanet A, Martín
E, Tárraga L, Rentz DM, Amariglio RE, Ruíz A, BoadaM. 2015. Concordance
between subjective and objective memory impairment in volunteer subjects. Journal
of Alzheimer’s Disease 48:1109–1117 DOI 10.3233/JAD-150594.
American Psychiatric Association. 2013.Diagnostic and statistical manual of mental
disorders (DSM-5 R©). Arlington: American Psychiatric Pub.
Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA. 2008.
Patient perspectives on the impact of fibromyalgia. Patient Education and Counseling
73:114–120 DOI 10.1016/j.pec.2008.06.005.
Baddeley A. 1996. Exploring the central executive. The Quarterly Journal of Experimental
Psychology Section A 49:5–28 DOI 10.1080/713755608.
Baddeley AD, Hitch G. 1974. Working memory. In: Psychology of learning and motiva-
tion. Stirling: Elsevier, 47–89.
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 16/22
Baddeley A, Logie R, Bressi S, Sala SD, Spinnler H. 1986. Dementia and work-
ing memory. The Quarterly Journal of Experimental Psychology 38:603–618
DOI 10.1080/14640748608401616.
Balash Y, MordechovichM, Shabtai H, Giladi N, Gurevich T, Korczyn AD. 2013.
Subjective memory complaints in elders: depression, anxiety, or cognitive decline?
Acta Neurologica Scandinavica 127:344–350.
Bar-On Kalfon T, Gal G, Shorer R, Ablin JN. 2016. Cognitive functioning in fi-
bromyalgia: the central role of effort. Journal of Psychosomatic Research 87:30–36
DOI 10.1016/j.jpsychores.2016.06.004.
Beck AT, Steer RA, Brown GK. 1996.Manual for the beck depression inventory-II. Vol. 1.
San Antonio: Psychological Corporation, 82.
Berryman C, Stanton TR, Bowering JK, Tabor A, McFarlane A, Moseley LG. 2013.
Evidence for working memory deficits in chronic pain: a systematic review and meta-
analysis. Pain 154:1181–1196 DOI 10.1016/j.pain.2013.03.002.
Burmester B, Leathem J, Merrick P. 2016. Subjective cognitive complaints and objective
cognitive function in aging: a systematic review and meta-analysis of recent cross-
sectional findings. Neuropsychology Review 26:376–393
DOI 10.1007/s11065-016-9332-2.
Carrillo-de-la PeñaMT, Triñanes Y, González-Villar A, Romero-Yuste S, Gómez-
Perretta C, Arias M,Wolfe F. 2015. Convergence between the 1990 and 2010
ACR diagnostic criteria and validation of the Spanish version of the Fibromyal-
gia Survey Questionnaire (FSQ). Rheumatology International 35:141–151
DOI 10.1007/s00296-014-3074-3.
Castel A, Cascón R, Salvat M, Sala J, Padrol A, Pérez M, Rull M. 2008. Rendimiento
cognitivo y percepción de problemas de memoria en pacientes con dolor crónico:
con fibromialgia versus sin fibromialgia. Revista de la Sociedad Española del Dolor
15:358–370.
CekoM, Bushnell MC, Gracely RH. 2012. Neurobiology underlying fibromyalgia
symptoms. Pain Research and Treatment 2012:585419 DOI 10.1155/2012/585419.
Cherry BJ, Zettel-Watson L, Shimizu R, Roberson I, Rutledge DN, Jones CJ. 2014.
Cognitive performance in women aged 50 years and older with and without
fibromyalgia. The Journals of Gerontology Series B: Psychological Sciences and Social
Sciences 69:199–208 DOI 10.1093/geronb/gbs122.
Chin J, Oh KJ, Seo SW, Na DL. 2014. Are depressive symptomatology and self-focused
attention associated with subjective memory impairment in older adults? Interna-
tional Psychogeriatrics 26:573–580 DOI 10.1017/S104161021300241X.
Coppieters I, Ickmans K, Cagnie B, Nijs J, De Pauw R, Noten S, Meeus M. 2015.
Cognitive performance is related to central sensitization and health-related quality
of life in patients with chronic whiplash-associated disorders and fibromyalgia. Pain
Physician 18:E389–E401.
Crombez G, Van RyckeghemDML, Eccleston C, Van Damme S. 2013. Atten-
tional bias to pain-related information: a meta-analysis. Pain 154:497–510
DOI 10.1016/j.pain.2012.11.013.
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 17/22
Crumley JJ, Stetler CA, Horhota M. 2014. Examining the relationship between subjective
and objective memory performance in older adults: a meta-analysis. Psychology and
Aging 29:250–263 DOI 10.1037/a0035908.
Cuevas-Toro AM, López-Torrecillas F, Díaz-BataneroMC, Pérez-Marfil MN. 2014.
Neuropsychological function, anxiety, depression and pain impact in fibromyalgia
patients. The Spanish Journal of Psychology 17:E78 DOI 10.1017/sjp.2014.78.
Di Tella M, Castelli L, Colonna F, Fusaro E, Torta R, Ardito RB, AdenzatoM. 2015.
Theory of mind and emotional functioning in fibromyalgia syndrome: an investiga-
tion of the relationship between social cognition and executive function. PLOS ONE
10:e0116542 DOI 10.1371/journal.pone.0116542.
Dick B, Eccleston C, Crombez G. 2002. Attentional functioning in fibromyalgia,
rheumatoid arthritis, and musculoskeletal pain patients. Arthritis and Rheumatism
47:639–644 DOI 10.1002/art.10800.
Gelonch O, Garolera M, Rosselló L, Pifarré J. 2013. Disfunción cognitiva en la fibromial-
gia. Revue Neurologique 56:573–588.
Gelonch O, Garolera M, Valls J, Rosselló L, Pifarré J. 2016. Executive function in fi-
bromyalgia: comparing subjective and objective measures. Comprehensive Psychiatry
66:113–122 DOI 10.1016/j.comppsych.2016.01.002.
Gelonch O, Garolera M, Valls J, Rosselló L, Pifarré J. 2017. Cognitive complaints in
women with fibromyalgia: are they due to depression or to objective cognitive
dysfunction? Journal of Clinical and Experimental Neuropsychology 39:1013–1025
DOI 10.1080/13803395.2017.1301391.
Glass JM. 2009. Review of cognitive dysfunction in fibromyalgia: a convergence on
working memory and attentional control impairments. Rheumatic Diseases Clinics
of North America 35:299–311 DOI 10.1016/j.rdc.2009.06.002.
Glass JM, Park DC. 2001. Cognitive dysfunction in fibromyalgia. Current Rheumatology
Reports 3:123–127 DOI 10.1007/s11926-001-0007-4.
Glass JM, Park DC, Minear M, Crofford LJ. 2005.Memory beliefs and func-
tion in fibromyalgia patients. Journal of Psychosomatic Research 58:263–269
DOI 10.1016/j.jpsychores.2004.09.004.
Glass JM,Williams DA, Fernandez-SanchezM-L, Kairys A, Barjola P, Heitzeg MM,
ClauwDJ, Schmidt-Wilcke T. 2011. Executive function in chronic pain patients
and healthy controls: different cortical activation during response inhibition in
fibromyalgia. The Journal of Pain 12:1219–1229 DOI 10.1016/j.jpain.2011.06.007.
González-Villar AJ, Pidal-MirandaM, Arias M, Rodríguez-Salgado D, Carrillo-
de-la PeñaMT. 2017. Electroencephalographic evidence of altered top-down
attentional modulation in fibromyalgia patients during a working memory task.
Brain Topography 30(4):539–547 DOI 10.1007/s10548-017-0561-3.
Grace GM, NielsonWR, Hopkins M, BergMA. 1999. Concentration and memory
deficits in patients with fibromyalgia syndrome. Journal of Clinical and Experi-
mental Neuropsychology (Neuropsychology, Development and Cognition: Section A)
21:477–487 DOI 10.1076/jcen.21.4.477.876.
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 18/22
Hertzog C, Park DC, Morrell RW,MartinM. 2000. Ask and ye shall receive: behavioural
specificity in the accuracy of subjective memory complaints. Applied Cognitive
Psychology 14:257–275
DOI 10.1002/(SICI)1099-0720(200005/06)14:3<257::AID-ACP651>3.0.CO;2-O.
IBM SPSS. 2011. IBM SPSS statistics for Windows. Version 20.0. New York: IBM Corp.
Jamison RN, Sbrocco T, Parris WC. 1989. The influence of problems with con-
centration and memory on emotional distress and daily activities in chronic
pain patients. The International Journal of Psychiatry in Medicine 18:183–191
DOI 10.2190/FTR1-F9VX-CB8T-WPMC.
Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B,
Dufouil C, Ellis KA, Van Der FlierWM. 2014. A conceptual framework for research
on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s &
Dementia 10:844–852 DOI 10.1016/j.jalz.2014.01.001.
Katz RS, Heard AR, Mills M, Leavitt F. 2004. The prevalence and clinical impact of
reported cognitive difficulties (fibrofog) in patients with rheumatic disease with
and without fibromyalgia. Journal of Clinical Rheumatology: Practical Reports on
Rheumatic & Musculoskeletal Diseases 10:53–58
DOI 10.1097/01.rhu.0000120895.20623.9f.
Kim S-H, Kim S-H, Kim S-K, Nam EJ, Han SW, Lee SJ. 2012. Spatial versus verbal
memory impairments in patients with fibromyalgia. Rheumatology International
32:1135–1142 DOI 10.1007/s00296-010-1762-1.
Kravitz HM, Katz RS. 2015. Fibrofog and fibromyalgia: a narrative review and
implications for clinical practice. Rheumatology International 35:1115–1125
DOI 10.1007/s00296-014-3208-7.
Landrø NI, Stiles TC, Sletvold H. 1997.Memory functioning in patients with primary
fibromyalgia and major depression and healthy controls. Journal of Psychosomatic
Research 42:297–306 DOI 10.1016/S0022-3999(96)00301-7.
Leavitt F, Katz RS. 2008. Speed of mental operations in fibromyalgia: a selective naming
speed deficit. Journal of Clinical Rheumatology: Practical Reports on Rheumatic &
Musculoskeletal Diseases 14:214–218 DOI 10.1097/RHU.0b013e31817a2472.
Lozoya-Delgado P, Ruiz-Sánchez de León JM, Pedrero-Pérez EJ. 2012. Validación de
un cuestionario de quejas cognitivas para adultos jóvenes: relación entre las quejas
subjetivas de memoria, la sintomatología prefrontal y el estrés percibido. Revista de
Neurología 54:137–150.
Luerding R,Weigand T, Bogdahn U, Schmidt-Wilcke T. 2008.Working memory
performance is correlated with local brain morphology in the medial frontal and
anterior cingulate cortex in fibromyalgia patients: structural correlates of pain–
cognition interaction. Brain 131:3222–3231 DOI 10.1093/brain/awn229.
Martinsen S, Flodin P, Berrebi J, LöfgrenM, Bileviciute-Ljungar I, Ingvar M,
Fransson P, Kosek E. 2014. Fibromyalgia patients had normal distraction re-
lated pain inhibition but cognitive impairment reflected in caudate nucleus
and hippocampus during the stroop color word test. PLOS ONE 9:e108637
DOI 10.1371/journal.pone.0108637.
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 19/22
McCracken LM, Iverson GL. 2001. Predicting complaints of impaired cognitive func-
tioning in patients with chronic pain. Journal of Pain and Symptom Management
21:392–396 DOI 10.1016/S0885-3924(01)00267-6.
Miyake A, Shah P. 1999.Models of working memory: mechanisms of active maintenance
and executive control. Cambridge: Cambridge University Press.
Mohs R, Mease P, Arnold LM,Wang F, Ahl J, Gaynor PJ, WohlreichMM. 2012.
The effect of duloxetine treatment on cognition in patients with fibromyalgia.
Psychosomatic Medicine 74:628–634 DOI 10.1097/PSY.0b013e31825b9855.
Munguía-Izquierdo D, Legaz-Arrese A, Moliner-Urdiales D, Reverter-Masía J. 2008.
Neuropsychological performance in patients with fibromyalgia syndrome: relation to
pain and anxiety. Psicothema 20:427–431.
Oldfield RC. 1971. The assessment and analysis of handedness: the Edinburgh inventory.
Neuropsychologia 9:97–113 DOI 10.1016/0028-3932(71)90067-4.
Park DC, Glass JM, Minear M, Crofford LJ. 2001. Cognitive function in fibromyalgia
patients. Arthritis & Rheumatology 44:2125–2133
DOI 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1.
Peirce JW. 2008. Generating stimuli for neuroscience using PsychoPy. Frontiers in
Neuroinformatics 2:10 DOI 10.3389/neuro.11.010.2008.
Petrides M, Alivisatos B, Meyer E, Evans AC. 1993. Functional activation of the human
frontal cortex during the performance of verbal working memory tasks. Proceedings
of the National Academy of Sciences of the United States of America 90:878–882
DOI 10.1073/pnas.90.3.878.
Queiroz LP. 2013.Worldwide epidemiology of fibromyalgia. Current Pain and Headache
Reports 17:356 DOI 10.1007/s11916-013-0356-5.
Roldán-Tapia L, Cánovas-López R, Cimadevilla J, ValverdeM. 2007. Cognition and
perception deficits in fibromyalgia and rheumatoid arthritis. Reumatología Clinica
3:101–109 DOI 10.1016/S1699-258X(07)73676-8.
Schmaling KB, Betterton KL. 2016. Neurocognitive complaints and functional status
among patients with chronic fatigue syndrome and fibromyalgia. Quality of Life
Research 25:1257–1263 DOI 10.1007/s11136-015-1160-y.
Schmidt-Wilcke T, Kairys A, Ichesco E, Fernandez-SanchezML, Barjola P, Heitzeg M,
Harris RE, ClauwDJ, Glass J, Williams DA. 2014. Changes in clinical pain in fi-
bromyalgia patients correlate with changes in brain activation in the cingulate cortex
in a response inhibition task. Pain Medicine 15:1346–1358 DOI 10.1111/pme.12460.
SedóMA. 2004. ‘‘5 digit test’’: a multilinguistic non-reading alternative to the Stroop test.
Revista de Neurologia 38:824–828.
Seo J, Kim S-H, Kim Y-T, Song H, Lee J, Kim S-H, Han SW, Nam EJ, Kim S-K, Lee HJ,
Lee S-J, Chang Y. 2012.Working memory impairment in fibromyalgia patients
associated with altered frontoparietal memory network. PLOS ONE 7:e37808
DOI 10.1371/journal.pone.0037808.
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 20/22
Stenfors CUD,Marklund P, Magnusson Hanson LL, Theorell T, Nilsson L-G.
2013. Subjective cognitive complaints and the role of executive cognitive func-
tioning in the working population: a case-control study. PLOS ONE 8:e83351
DOI 10.1371/journal.pone.0083351.
Suhr JA. 2003. Neuropsychological impairment in fibromyalgia. Journal of Psychosomatic
Research 55:321–329 DOI 10.1016/S0022-3999(02)00628-1.
Sunderland A, Harris JE, Gleave J. 1984.Memory failures in everyday life following
severe head injury. Journal of Clinical and Experimental Neuropsychology 6:127–142
DOI 10.1080/01688638408401204.
Svendsen AM, Kessing LV, Munkholm K, VinbergM,Miskowiak KW. 2012. wal.
Nordic Journal of Psychiatry 66:248–253 DOI 10.3109/08039488.2011.626870.
Tesio V, Torta DME, Colonna F, Leombruni P, Ghiggia A, Fusaro E, Geminiani GC,
Torta R, Castelli L. 2015. Are fibromyalgia patients cognitively impaired? objective
and subjective neuropsychological evidence: cognitive impairment in FM. Arthritis
Care & Research 67:143–150 DOI 10.1002/acr.22403.
Tirapu-Ustárroz J, Muñoz Céspedes JM, Pelegrín-Valero C, Albéniz-Ferreras A. 2005.
Propuesta de un protocolo para la evaluación de las funciones ejecutivas. Revista de
Neurología 41:177–186.
Veldhuijzen DS, Sondaal SFV, Oosterman JM. 2012. Intact cognitive inhibition in
patients with fibromyalgia but evidence of declined processing speed. The Journal
of Pain 13:507–515 DOI 10.1016/j.jpain.2012.02.011.
Verdejo-García A, Bechara A. 2010. Neuropsicología de las funciones ejecutivas.
Psicothema 22:227–235.
Walitt B, ČekoM, KhatiwadaM, Gracely JL, Rayhan R, VanMeter JW, Gracely RH.
2016. Characterizing ‘‘fibrofog’’: subjective appraisal, objective performance, and
task-related brain activity during a working memory task. NeuroImage: Clinical
11:173–180 DOI 10.1016/j.nicl.2016.01.021.
Walteros C, Sánchez-Navarro JP, MuñozMA,Martínez-Selva JM, Chialvo D, Montoya
P. 2011. Altered associative learning and emotional decision making in fibromyalgia.
Journal of Psychosomatic Research 70:294–301 DOI 10.1016/j.jpsychores.2010.07.013.
Wechsler D. 1997.WAiS-iii. Antonio: Psychological Corporation San.
Williams DA, ClauwDJ, Glass JM. 2011. Perceived cognitive dysfunction in fibromyalgia
syndrome. Journal of Musculoskeletal Pain 19:66–75
DOI 10.3109/10582452.2011.558989.
Wolfe F, ClauwDJ, Fitzcharles M-A, Goldenberg DL, Katz RS, Mease P, Russell AS,
Russell IJ, Winfield JB, YunusMB. 2010. The American college of rheumatology
preliminary diagnostic criteria for fibromyalgia and measurement of symptom
severity. Arthritis Care & Research 62:600–610 DOI 10.1002/acr.20140.
Wolfe F, Smythe HA, YunusMB, Bennett RM, Bombardier C, Goldenberg DL,
Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ,
Michael Franklin C, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT,
Mccain GA, John ReynoldsW, Romano TJ, Jon Russell I, Sheon RP. 1990. The
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 21/22
american college of rheumatology 1990 criteria for the classification of fibromyalgia.
Arthritis & Rheumatism 33:160–172 DOI 10.1002/art.1780330203.
WuY-L, Huang C-J, Fang S-C, Ko L-H, Tsai P-S. 2018. Cognitive impairment in
fibromyalgia: a meta-analysis of case–control studies. Psychosomatic Medicine
80(5):432–438 DOI 10.1097/PSY.0000000000000575.
Pidal-Miranda et al. (2018), PeerJ, DOI 10.7717/peerj.5907 22/22
